JPH0819161B2 - Novel glycosphingolipid-related compounds - Google Patents

Novel glycosphingolipid-related compounds

Info

Publication number
JPH0819161B2
JPH0819161B2 JP8643394A JP8643394A JPH0819161B2 JP H0819161 B2 JPH0819161 B2 JP H0819161B2 JP 8643394 A JP8643394 A JP 8643394A JP 8643394 A JP8643394 A JP 8643394A JP H0819161 B2 JPH0819161 B2 JP H0819161B2
Authority
JP
Japan
Prior art keywords
compound
group
toluene
nmr
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP8643394A
Other languages
Japanese (ja)
Other versions
JPH07118302A (en
Inventor
智也 小川
佐藤  進
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
RIKEN Institute of Physical and Chemical Research
Original Assignee
Sankyo Co Ltd
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd, RIKEN Institute of Physical and Chemical Research filed Critical Sankyo Co Ltd
Priority to JP8643394A priority Critical patent/JPH0819161B2/en
Publication of JPH07118302A publication Critical patent/JPH07118302A/en
Publication of JPH0819161B2 publication Critical patent/JPH0819161B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規なフコース置換ラ
クト系列スフィンゴ糖脂質関連化合物に関する。
TECHNICAL FIELD The present invention relates to a novel fucose-substituted lactoseries glycosphingolipid-related compound.

【従来の技術】分化抗原の1つであるSSEA−1抗原
(Stage-specific Embryonic Antigen)は、1978
年、ソルター(Solter)とノウルズ(Knowles)等(ディ
ー・ソルター及びビー・ビー・ノウルズ:Proc. Natl.
Acad. Sci. USA.,75、5565〜5569、197
8)が、マウスのテトラカルチノーマ細胞F9を同系マ
ウスに免疫して得たモノクローナル抗体が認識する抗原
である。その構造は非還元末端に抗原決定基としてLe
X 構造を有したフコース置換ラクト系列スフィンゴ糖脂
質であることが、1982年、箱守等〔アール.カンナ
ギ,イー・ヌーデルマン,エス・ビー・レベリー及びエ
ス・ハコモリ(R. Kannagi, B. Nudelman, S.B. Levery
and S. Hakomori):J. Biol. Chem., 257、148
65〜14878、1982;アール.カンナギ,イー
・ヌーデルマン及びエス・ハコモリ(R.Kannagi, E. Nu
delman, and S. Hakomori) : Proc. Natl. Acad. Sci.
USA.,79、3470〜3474、1982〕により、
明らかにされた。
2. Description of the Related Art SSEA-1 antigen (Stage-specific Embryonic Antigen), which is one of the differentiation antigens, is 1978.
Year, Solter and Knowles, etc. (Dee Salter and BB Knowles: Proc. Natl.
Acad. Sci. USA., 75, 5565-5569, 197.
8) is an antigen recognized by a monoclonal antibody obtained by immunizing a syngeneic mouse with mouse tetracarcinoma cell F9. Its structure is Le as an antigenic determinant at the non-reducing end.
The fucose-substituted lactoseries glycosphingolipid having an X structure was reported in 1982 by Hakomori et al. Kannagi, B. Nudelman, SB Levery
and S. Hakomori): J. Biol. Chem., 257, 148.
65-14878, 1982; Earl. R. Kannagi, E. Nuderman and R. Kannagi, E. Nu
delman, and S. Hakomori): Proc. Natl. Acad. Sci.
USA., 79, 3470-3474, 1982],
Was revealed.

【0002】これらは当初考えられていた、単一な抗原
分子ではなく、そのN−アセチルラクトサミン構造の活
発な延長と、フコシル化の程度により、多種多様な糖鎖
群を形成し、各種ガン組織から、ガン関連糖脂質として
単離されて来た。〔エッチ・ジェイ・ヤング及びエス・
ハコモリ(H. J. Yang and S. Hakomori) :J. Biol.Ch
em., 246、1192、1971;エス・ハコモリ,
イー・ヌーデルマン,エス・ビー・レベリー及びアール
・カンナギ(S. Hakomori, E. Nudelman, S. B. Levery
and R. Kannagi):J. Biol. Chem., 259、467
2、1982;ワイ・フクシ,エス・ハコモリ,イー・
ヌーデルマン及びエヌ・エー・コチラン(Y. Fukushi,
S. Hakomori, E. Nudelman and N. A. Cochran) :25
9、4681〜4685、1984〕。
These are not initially thought of as a single antigen molecule, but they form a wide variety of sugar chain groups depending on the extent of fucosylation and the active extension of the N-acetyllactosamine structure, resulting in various cancers. It has been isolated from tissues as a cancer-associated glycolipid. [H. Jay Young and S.
Hakomori (HJ Yang and S. Hakomori): J. Biol.Ch
em., 246, 1192, 1971; S. Hakomori,
S. Hakomori, E. Nudelman, SB Levery
and R. Kannagi): J. Biol. Chem., 259, 467.
2, 1982; Fukushi Wai, S. Hakomori, E.
Nudermann and NA Cochilan (Y. Fukushi,
S. Hakomori, E. Nudelman and NA Cochran): 25
9, 4681-4685, 1984].

【0003】本発明者らはこうしたSSEA−1抗原群
の基本構造ともいえる5糖残基からなる糖脂質(Lex ) Galβ1→4[Fucα1→3] GlcNAcβ1→3Galβ1→4Gl
cβ1→ Cer の合成に成功している。
The present inventors have found that the glycolipid (Le x ) Galβ1 → 4 [Fucα1 → 3] GlcNAcβ1 → 3Galβ1 → 4Gl consisting of five sugar residues, which can be said to be the basic structure of the SSEA-1 antigen group.
Successful synthesis of cβ1 → Cer.

【0004】[0004]

【発明が解決しようとする課題】さらに、高次にガン化
と密接に関連していると思われる、Lex をくり返し構
造として有した8糖残基からなる糖脂質(2Lex ) Galβ1→4[Fucα1→3] GlcNAcβ1→ Galβ1→4
[Fucα1→3] GlcNAcβ1→3Galβ1→4Glcβ1→ Cer の精密合成は、これら、ガン関連糖鎖の生化学的役割の
解明を有機化学的見地から推進する上で必要不可欠であ
り、またこれらの糖脂質は将来的には、診断、治療等へ
の応用が期待されるなど、意義あるものである。本発明
の目的は、8糖残基からなるスフィンゴ糖脂質関連化合
物2Lex の合成に重要な中間体となるスフィンゴ糖脂質
関連化合物を提供することである。
THE INVENTION Problems to be Solved] In addition, appears to be closely related to the canceration in order, glycolipids of 8 sugar residues having a Le x repeated as structure (2Le x) Galβ1 → 4 [Fucα1 → 3] GlcNAcβ1 → Galβ1 → 4
Precise synthesis of [Fucα1 → 3] GlcNAcβ1 → 3Galβ1 → 4Glcβ1 → Cer is indispensable for promoting the elucidation of the biochemical role of these cancer-related sugar chains from the viewpoint of organic chemistry, and these glycolipids. Is significant as it is expected to be applied to diagnosis and treatment in the future. An object of the present invention is to provide a glycosphingolipid-related compound which is an important intermediate in the synthesis of a glycosphingolipid-related compound 2Le x consisting of 8 sugar residues.

【0005】[0005]

【課題を解決するための手段】本発明は、一般式〔I〕
で表わされるスフィンゴ糖脂質関連化合物を提供するも
のである。
The present invention has the general formula [I]
The present invention provides a glycosphingolipid-related compound represented by

【化2】 式中、R1 、R2 及びR3 は独立して水素原子、ベンジ
ル基またはアセチル基であり、R4 はフタロイルアミノ
基またはアセチルアミノ基であり、R5 はベンジル基、
アセチル基又は-C(=NH)-CCl3基である。本発明の上記化
合物は例えば、下記の工程(a) 〜(d) により製造するこ
とができる。 (a) 化合物〔15〕及び化合物〔16〕を反応せしめて
化合物〔17〕を製造する工程。 (b) 化合物〔17〕をヒドラジン処理してフタロイル基
を脱離し、次いでアセチル化して化〔19〕を製造する
工程。 (c) 化合物〔19〕を脱ベンジル化し、次いでアセチル
化して化合物〔20〕を製造する工程。 (d) 化合物〔20〕をヒドラジン/酢酸で処理した後、
トリクロロアセトニトリルで処理して化合物〔21〕を
製造する工程。
Embedded image In the formula, R 1 , R 2 and R 3 are independently a hydrogen atom, a benzyl group or an acetyl group, R 4 is a phthaloylamino group or an acetylamino group, R 5 is a benzyl group,
An acetyl group or a -C (= NH) -CCl 3 group. The above compound of the present invention can be produced, for example, by the following steps (a) to (d). (a) A step of reacting the compound [15] and the compound [16] to produce the compound [17]. (b) A step of treating compound [17] with hydrazine to eliminate the phthaloyl group and then acetylating to produce compound [19]. (c) A step of producing a compound [20] by debenzylating the compound [19] and then acetylating it. (d) After treating the compound [20] with hydrazine / acetic acid,
A step of producing compound [21] by treating with trichloroacetonitrile.

【0006】[0006]

【化3】 Embedded image

【0007】[0007]

【化4】 [Chemical 4]

【0008】[0008]

【化5】 Embedded image

【0009】[0009]

【化6】 [Chemical 6]

【0010】[0010]

【化7】 [Chemical 7]

【0011】[0011]

【化8】 Embedded image

【0012】最終化合物である8糖化合物(2Lex
は、例えば、工程(e) 及び(f) により製造することがで
きる。 (e) 化合物〔21〕とセラミド化合物〔22〕を反応せ
しめ、化合物〔23〕を製造する。 (f) 化合物〔23〕の保護基を脱離し、化合物〔1〕す
なわち、2Lex を製造する。
Octasaccharide compound (2Le x ) which is the final compound
Can be produced, for example, by steps (e) and (f). (e) Compound [21] is reacted with ceramide compound [22] to give compound [23]. (f) The protecting group of compound [23] is removed to produce compound [1], that is, 2Le x .

【0013】[0013]

【化9】 [Chemical 9]

【0014】[0014]

【化10】 [Chemical 10]

【0015】[0015]

【化11】 [Chemical 11]

【0016】この明細書中、Acはアセチル基、Bnはベン
ジル基、Phはフェニル基、Phthはフタロイル基を表わ
す。以下本発明のスフィンゴ糖脂質関連化合物の製造法
について、更に詳細に説明する。まず公知の化合物
〔2〕を、 NaOCH3 ,NaOEt ,Na2CO3 , NaHCO3 等の塩
基の存在下、メタノール、エタノール等の溶媒中で−1
0℃〜80℃にて5分間〜1日間処理して、脱アセチル
化し、新規な化合物〔3〕を得る。次いでDMF(ジメ
チルホルムアミド)、アセトン、THF(テトラヒドロ
フラン)、トルエンまたはジオキサンのような溶媒中
で、トルエンスルホン酸、ベンゼンスルホン酸、無水塩
酸または塩化亜鉛等の存在下、化合物〔3〕をジメトキ
シプロパンと0℃〜120℃で1時間〜2日間反応させ
イソプロピリデン化して、新規な化合物〔4〕を得る。
この際副生物として新規な化合物〔5〕も得られる。次
いでDMF、THFまたはジオキサン等のような溶媒中
で化合物〔4〕にベンジルブロマイド、酸化銀及びヨウ
化カリウムを−20〜100℃で5分間〜1日間反応さ
せ、ベンジル化して新規な化合物〔6〕を得る。更に、
化合物〔6〕をトリフルオロ酢酸/水、酢酸/水または
希塩酸等によって、−10゜〜100℃で5分間〜1日
間処理してイソプロピリデン基を脱離し、新規な化合物
〔8〕を得る。この際、フコースが脱離した新規な化合
物〔7〕も副生物として生成する。
In this specification, Ac represents an acetyl group, Bn represents a benzyl group, Ph represents a phenyl group, and Phth represents a phthaloyl group. Hereinafter, the method for producing the glycosphingolipid-related compound of the present invention will be described in more detail. First known compound (2), NaOCH 3, NaOEt, Na 2 CO 3, NaHCO presence of a base such as 3, methanol, ethanol and the like in a solvent -1
It is deacetylated by treating at 0 ° C to 80 ° C for 5 minutes to 1 day to obtain a novel compound [3]. Then, in a solvent such as DMF (dimethylformamide), acetone, THF (tetrahydrofuran), toluene or dioxane, the compound [3] is converted to dimethoxypropane in the presence of toluenesulfonic acid, benzenesulfonic acid, anhydrous hydrochloric acid or zinc chloride. A novel compound [4] is obtained by reacting at 0 ° C to 120 ° C for 1 hour to 2 days for isopropylidene formation.
At this time, a novel compound [5] is also obtained as a by-product. Then, the compound [4] is reacted with benzyl bromide, silver oxide and potassium iodide at −20 to 100 ° C. for 5 minutes to 1 day in a solvent such as DMF, THF or dioxane to benzylate the novel compound [6]. ]] Is obtained. Furthermore,
The compound [6] is treated with trifluoroacetic acid / water, acetic acid / water, dilute hydrochloric acid or the like at −10 ° to 100 ° C. for 5 minutes to 1 day to eliminate the isopropylidene group to obtain a novel compound [8]. At this time, a novel compound [7] from which fucose has been eliminated is also produced as a by-product.

【0017】[0017]

【化12】 [Chemical 12]

【0018】[0018]

【化13】 [Chemical 13]

【0019】[0019]

【化14】 Embedded image

【0020】次いでピリジン、ジクロロエタン、ジクロ
ロメタン、クロロホルム、THFまたはジオキサン等の
溶媒中、化合物〔8〕を温度−10〜80℃で5分間〜
2日間無水酢酸と反応させてアセチル化し、新規な化合
Then, the compound [8] is heated in a solvent such as pyridine, dichloroethane, dichloromethane, chloroform, THF or dioxane at a temperature of -10 to 80 ° C for 5 minutes to
A novel compound that is acetylated by reacting with acetic anhydride for 2 days

〔9〕を得る。更に、酢酸水溶液、メタノールまたは
エタノール等の溶媒中で化合物
Obtain [9]. In addition, the compound in a solvent such as acetic acid aqueous solution, methanol or ethanol

〔9〕を塩化パラジウム
により0〜120℃で30分間〜2日間処理し、化合物
〔10〕を得る。次いでクロロホルム、ジクロロメタ
ン、ジクロロエタン、トルエンまたはTHF等の溶媒中
で、DBU(ジアザビシクロウンデカン)存在下、−2
0〜60℃で、5分間〜1日間化合物〔10〕をトリク
ロロアセトニトリルと反応させ、新規な化合物〔11〕
を得る。更にクロロホルム、ジクロロメタン、ジクロロ
エタン、トルエンまたはTHF等の溶媒中でBF3 ・E
2 OまたはTMSOTf (トリメチルシリルトリフレ
ート)、等のグリシコル化触媒存在下、化合物〔11〕
に、化合物〔12〕を反応させて5糖残基からなる新規
な化合物〔13〕を得る。副生物として化合物〔14〕
も得られる。
Compound [10] is obtained by treating [9] with palladium chloride at 0 to 120 ° C. for 30 minutes to 2 days. Then, in a solvent such as chloroform, dichloromethane, dichloroethane, toluene or THF in the presence of DBU (diazabicycloundecane), -2
The compound [10] is reacted with trichloroacetonitrile at 0 to 60 ° C. for 5 minutes to 1 day to give a novel compound [11].
Get. In a solvent such as chloroform, dichloromethane, dichloroethane, toluene or THF, BF 3 · E
Compound [11] in the presence of a glycicylation catalyst such as t 2 O or TMSOTf (trimethylsilyl triflate)
Then, the compound [12] is reacted to obtain a novel compound [13] having a pentasaccharide residue. Compound [14] as a by-product
Can also be obtained.

【0021】[0021]

【化15】 [Chemical 15]

【0022】[0022]

【化16】 Embedded image

【0023】[0023]

【化17】 [Chemical 17]

【0024】次いで化合物〔13〕を、メタノール、エ
タノール等の溶媒中、−10〜80℃で5分間〜1日
間、NaOCH3 , NaOC2H5 , Na2CO3 または NaHCO3 等に
より処理して脱アセチル化し、新規な化合物〔15〕を
得る。更にクロロホルム、ジクロロメタン、ジクロロエ
タン、トルエンまたはTHF等の溶媒中で、BF3 ・E
2 OまたはTMSOTf 等の触媒存在下、化合物〔1
5〕に公知の化合物〔16〕を、−20〜60℃で5分
間〜1日間反応させ新規な化合物〔17〕及び副生物と
して新規な化合物〔18〕を得る。
Then, the compound [13] is treated with NaOCH 3 , NaOC 2 H 5 , Na 2 CO 3 or NaHCO 3 in a solvent such as methanol or ethanol at −10 to 80 ° C. for 5 minutes to 1 day. Deacetylation gives a new compound [15]. Further, in a solvent such as chloroform, dichloromethane, dichloroethane, toluene or THF, BF 3 · E
In the presence of a catalyst such as t 2 O or TMSOTf, the compound [1
The known compound [16] in 5] is reacted at −20 to 60 ° C. for 5 minutes to 1 day to obtain a novel compound [17] and a novel compound [18] as a by-product.

【0025】[0025]

【化18】 Embedded image

【0026】更に化合物〔17〕を、メタノールまたは
エタノール等の溶媒中、0〜120℃で5分間〜2日間
ヒドラジン処理してフタロイル基を脱離した後、ピリジ
ン、クロロホルム、ジクロロエタン、ジクロロメタンま
たはTHF等の溶媒中、−10〜80℃で30分間〜2
日間、必要により4−DMAP(4−ジメチルアミノピリジ
ン)存在下、無水酢酸と反応させてアセチル化し、新規
な化合物〔19〕を得る。次いでメタノール、エタノー
ルまたは酢酸等の溶媒中、10%Pd −C、5%Pd −
BaSO4 、5%Pt −C等の触媒存在下、化合物〔19〕
を0〜100℃で1時間〜3日間水素接触還元して脱ベ
ンジル化した後、ピリジン、クロロホルム、ジクロロエ
タン、ジクロロメタンまたはTHF等の溶媒中で、無水
酢酸、ピリジン及び4−DMAPと、−10〜80℃で
30分間〜2日間反応させてアセチル化し、新規な化合
物〔20〕(収率78%)を得る。次いでDMF、DM
SO、THFまたはジオキシサン等の溶媒中でヒドラジ
ン・酢酸存在下、化合物〔20〕を−10〜100℃で
5分間〜1日間処理して1位のアセチル基を脱離し、さ
らにクロロホルム、ジクロロメタン、ジクロロエタン、
トルエンまたはTHF等の溶媒中で、DBU存在下、−
20℃〜60℃で5分間〜1日間トリクロロアセトニト
リルと反応させて化合物〔21〕を得る。次いでクロロ
ホルム、ジクロロメタン、ジクロロエタン、トルエンま
たはTHF等の溶媒中で、BF3 ・Et2 O及びTMS
OTf 等の触媒存在下、−20〜60℃で5分間〜1日
間、化合物〔21〕とセラミド化合物〔22〕を反応せ
しめ新規な化合物〔23〕を得る。この際、副生物とし
て新規な化合物〔24〕が得られる。
Further, the compound [17] is treated with hydrazine in a solvent such as methanol or ethanol at 0 to 120 ° C. for 5 minutes to 2 days to eliminate the phthaloyl group, and then pyridine, chloroform, dichloroethane, dichloromethane or THF. In a solvent of 10 to 80 ° C. for 30 minutes to 2
For a day, if necessary, it is reacted with acetic anhydride in the presence of 4-DMAP (4-dimethylaminopyridine) to acetylate to obtain a novel compound [19]. Then, in a solvent such as methanol, ethanol or acetic acid, 10% Pd-C, 5% Pd-
Compound [19] in the presence of a catalyst such as BaSO 4 and 5% Pt-C
Is dehydrogenated by hydrogen catalytic reduction at 0 to 100 ° C. for 1 hour to 3 days, and then acetic anhydride, pyridine and 4-DMAP are added to -10 to 10 in a solvent such as pyridine, chloroform, dichloroethane, dichloromethane or THF. Acetylation is performed by reacting at 80 ° C. for 30 minutes to 2 days to obtain a novel compound [20] (yield 78%). Then DMF, DM
Compound [20] is treated in the presence of hydrazine / acetic acid in a solvent such as SO, THF or dioxysan at -10 to 100 ° C for 5 minutes to 1 day to remove the acetyl group at the 1-position, and then chloroform, dichloromethane or dichloroethane. ,
In a solvent such as toluene or THF in the presence of DBU,
Compound [21] is obtained by reacting with trichloroacetonitrile at 20 ° C to 60 ° C for 5 minutes to 1 day. Then, in a solvent such as chloroform, dichloromethane, dichloroethane, toluene or THF, BF 3 · Et 2 O and TMS are added.
The compound [21] is reacted with the ceramide compound [22] at −20 to 60 ° C. for 5 minutes to 1 day in the presence of a catalyst such as OTf to obtain a novel compound [23]. At this time, a novel compound [24] is obtained as a by-product.

【0027】[0027]

【化19】 [Chemical 19]

【0028】次いでTHFまたはジオキサン等の溶媒中
でn−Bu4NF存在下、化合物〔23〕を−20〜10
0℃で5分間〜2日間反応せしめた後、メタノール、エ
タノールまたはTHF等の溶媒中で、NaOCH3、NaOC
2H5 、Na2CO3またはNaHCO3等の塩基により、−10〜8
0℃で5分間〜1日間処理してアセチル基を脱離し、目
的の化合物〔1〕(2Lex )を得る。
[0028] Then n-Bu 4 NF presence in a solvent such as THF or dioxane, compound [23] -20~10
After reacting at 0 ° C. for 5 minutes to 2 days, the reaction mixture is added with a solvent such as methanol, ethanol or THF to obtain NaOCH 3 , NaOC.
With a base such as 2 H 5 , Na 2 CO 3 or NaHCO 3 , -10 to 8
The target compound [1] (2Le x ) is obtained by removing the acetyl group by treatment at 0 ° C. for 5 minutes to 1 day.

【0029】[0029]

【発明の効果】本発明のスフィンゴ糖脂質関連化合物
は、ガン関連糖鎖の生化学的役割の解明を有機化学的見
地から推進するために必要不可欠な8糖化合物である2
Lex の合成中間体として重要なものである。この2Lex
は、SSEA−1抗原群の基本構造である8糖残基から
なる糖脂質であり、これを抗原として形成された抗SS
EA−1抗体は、血清腫瘍マーカーとして、肺腺癌、卵
巣癌、膵癌等の診断、治療等に応用することができる。
また本発明のスフィンゴ糖脂質関連化合物を使用するこ
とによって、2Lex を収率よく製造することができる。
The glycosphingolipid-related compound of the present invention is an octasaccharide compound essential for promoting the elucidation of the biochemical role of cancer-related sugar chains from the viewpoint of organic chemistry.
It is an important synthetic intermediate for Le x . This 2 Le x
Is a glycolipid consisting of octasaccharide residues which is a basic structure of SSEA-1 antigen group, and anti-SS formed using this as a antigen
The EA-1 antibody can be applied as a serum tumor marker in the diagnosis and treatment of lung adenocarcinoma, ovarian cancer, pancreatic cancer and the like.
Moreover, 2Le x can be produced in good yield by using the glycosphingolipid-related compound of the present invention.

【0030】次に参考例及び実施例によって本発明を更
に具体的に説明する。 〔参考例1〕(化合物〔3〕の合成) 化合物〔2〕5.62g(4.73mM)をメタノール/T
HF(20ml/20ml)に溶解し、これに、0.2N NaO
CH3 メタノール溶液5mlを加え室温にて、1時間攪拌し
た。反応終了後、アンバーリスト15を加え、反応溶液
を中和後、ろ去し、ろ液を減圧留去した。残渣をカラム
クロマトグラフィー(アセトン/トルエン=1/1展
開)にて、精製し、油状物4.82g(収率、定量的)を
得た。 Rf =0.46(トルエン/アセトン=1/1) 〔α〕D 25−19.9°(C=0.88、 CHCl3) 元素分析値: C57H63NO16 ・1/2H2O=1027.141として 計算値 C;66.65 H;6.28 N;1.36 測定値 C;66.68 H;6.27 N;1.341 H−NMR(400MHz、CDC13)δ;7.75−6.9
8(m,24H,アロマチックH),5.736 (m, 1H, -CH2 -CH=C
H2),5.219(d,1H,H-1a, J=8.8Hz),5.145 (dd,1H,=CH
2, J=1.5, 17.4HZ),5.061 (dd, 1H,=CH 2, J=1.5, 1
0.8Hz),4.873(d, 1H, H-1c, J=2.7Hz),4.489 (d, 1
H, H-1b, J=7.0Hz),1.052 (d, 3H,H-6c, J=6.4Hz)13 C−NMR(CDCl3)δ;168.230(=O), 99.85
3(C-1b),98.661(C-1a),96.984(C-1c), 55.860(C-2a),
16.362(C-6c)
The present invention will be described in more detail with reference to Reference Examples and Examples. [Reference Example 1] (Synthesis of Compound [3]) Compound [2] (5.62 g, 4.73 mM) was added to methanol / T.
Dissolve in HF (20ml / 20ml) and add 0.2N NaO
5 ml of CH 3 methanol solution was added and stirred at room temperature for 1 hour. After completion of the reaction, Amberlyst 15 was added to neutralize the reaction solution, which was then filtered off, and the filtrate was evaporated under reduced pressure. The residue was purified by column chromatography (acetone / toluene = 1/1 development) to obtain 4.82 g (yield, quantitative) of an oil. Rf = 0.46 (toluene / acetone = 1/1) [α] D 25 -19.9 ° (C = 0.88 , CHCl 3) Elemental analysis: C 57 H 63 NO 16 · 1 / 2H 2 O = 1027.141 calculated value C; 66.65 H; 6.28 N; 1.36 measured value C; 66.68 H; 6.27 N; 1.34 1 H-NMR (400 MHz, CDC1 3 ) δ; 7.75-6.9
8 (m, 24H, aromatic H), 5.736 (m, 1H, -CH 2 - CH = C
H 2 ), 5.219 (d, 1H, H-1a, J = 8.8Hz), 5.145 (dd, 1H, = CH
2 , J = 1.5, 17.4HZ), 5.061 (dd, 1H, = CH 2 , J = 1.5, 1
0.8Hz), 4.873 (d, 1H, H-1c, J = 2.7Hz), 4.489 (d, 1
H, H-1b, J = 7.0 Hz), 1.052 (d, 3H, H-6c, J = 6.4 Hz) 13 C-NMR (CDCl 3 ) δ; 168.230 ( C ═O), 99.85
3 (C-1b), 98.661 (C-1a), 96.984 (C-1c), 55.860 (C-2a),
16.362 (C-6c)

【0031】 〔参考例2〕(化合物〔4〕及び〔5〕の合成) 化合物〔3〕4.58g(4.5mM)を、DMF20mlに
溶解し、これに、ジメトキシプロパン4.68g(45m
M)及びp−TsOH300mgを加え、室温にて、2日間攪
拌した。反応終了後、トリエチルアミンを加え中和後、
酢酸エチルで抽出し、水、飽和食塩水で順次洗浄後、硫
酸マグネシウムで乾燥し、溶媒を留去した。残渣をメタ
ノール50mlに溶解し、これにアンバーリスト15を加
え、室温にて30分攪拌後、濾過し、濾液を減圧留去し
た。残渣をカラムクロマトグラフィー(トルエン/アセ
トン=5/1 展開)にて精製し、化合物〔4〕3.52g
(収率 73.9%)及び化合物〔5〕0.77g(収率1
6.2g)を得た。
Reference Example 2 (Synthesis of Compounds [4] and [5]) Compound [3] (4.58 g, 4.5 mM) was dissolved in DMF (20 ml), and dimethoxypropane (4.68 g, 45 m) was added.
M) and p-TsOH (300 mg) were added, and the mixture was stirred at room temperature for 2 days. After the reaction is completed, neutralize by adding triethylamine,
The mixture was extracted with ethyl acetate, washed successively with water and saturated brine, dried over magnesium sulfate, and the solvent was evaporated. The residue was dissolved in 50 ml of methanol, Amberlyst 15 was added thereto, the mixture was stirred at room temperature for 30 minutes, filtered, and the filtrate was evaporated under reduced pressure. The residue was purified by column chromatography (toluene / acetone = 5/1 development) and compound [4] 3.52 g
(Yield 73.9%) and Compound [5] 0.77 g (Yield 1
6.2 g) was obtained.

【0032】化合物〔4〕 Rf =0.65 (トルエン/アセトン=2/1) 〔α〕D 25−7.0°(C=0.79、 CHCl3) 元素分析値:C60H67NO16=1058.199として 計算値 C; 68.10 H; 6.38 N; 1.32 測定値 C; 67.92 H; 6.43 N; 1.271 H−NMR(400MHz、CDCl3)δ;7.73-6.96
(m,24H, アロマチックH),5.727 (m, 1H,-CH2-CH=C
H2), 5.195(d, 1H, H-1a, J=8.5Hz),5.140 (dd,1H,=
CH2, J=1.5, 17.4Hz),5.055 (dd, 1H,=CH 2, J=1.5,
10.4Hz),4.784(d, 1H, H-1c, J=3.4Hz),4.396 (d,
1H, H-1b, J=8.2Hz),1.469, 1.313(2×s, 6H, =C
(CH3)2),1.052 (d, 3H, H-6c, J=6.4Hz)13 C−NMR(CDCl3)δ;168.178 (C=O), 110.20
4(=C(CH3)2), 99.476(C-1b) ,98.718(C-1a), 96.984(C
-1c), 55.914(C-2a),28.119, 26.277(C(CH3)2),16.525
(C-6c)
Compound [4] Rf = 0.65 (toluene / acetone = 2/1) [α] D 25 −7.0 ° (C = 0.79, CHCl 3 ) Elemental analysis value: C 60 H 67 NO Calculated as 16 = 1058.199 C; 68.10 H; 6.38 N; 1.32 Measured C; 67.92 H; 6.43 N; 1.27 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.73-6.96
(m, 24H, aromatic H), 5.727 (m, 1H, -CH 2 - CH = C
H 2 ), 5.195 (d, 1H, H-1a, J = 8.5Hz), 5.140 (dd, 1H, =
CH 2 , J = 1.5, 17.4Hz), 5.055 (dd, 1H, = CH 2 , J = 1.5,
10.4Hz), 4.784 (d, 1H, H-1c, J = 3.4Hz), 4.396 (d,
1H, H-1b, J = 8.2Hz), 1.469, 1.313 (2 × s, 6H, = C
(CH 3 ) 2 ), 1.052 (d, 3H, H-6c, J = 6.4 Hz) 13 C-NMR (CDCl 3 ) δ; 168.178 (C═O), 110.20
4 ( = C (CH 3 ) 2 ), 99.476 (C-1b), 98.718 (C-1a), 96.984 (C
-1c), 55.914 (C-2a), 28.119, 26.277 (C (CH 3 ) 2 ), 16.525
(C-6c)

【0033】化合物〔5〕 Rf =0.43 (トルエン/アセトン=2/1) 〔α〕D 24+2.5°(C=0.56、 CHCl3) 元素分析値: C60H67NO16 ・1/2H2O=1067.206 計算値 C; 67.53 H; 6.42 N; 1.31 測定値 C; 67.49 H; 6.39 N; 1.211 H−NMR(400MHz、CDCl3)δ;7.72-7.02
(m, 24H, アロマチックH),5.649 (m, 1H,-CH2-CH=C
H2),5.113 (d, 1H, H-1a, J=8.5Hz),5.070(dd, 1H,
CH 2, J=1.5, 17.1Hz),4.983 (dd, 1H,=CH 2, J=1.
5, 10.4Hz),4.833 (d, 1H, H-1c, J=3.7Hz),4.551
(d, 1H, H-1b, J=7.6Hz),1.392, 1.301 (2×s, 6H,
=C(CH3)2) ,1.098 (d, 3H, H-6c, J=6.4Hz)13 C−NMR(CDCl3)δ;168.013 (C=O), 101.426
(C-1b), 98.718 (=C(CH3)2) ,97.686(C-1a), 97.469(C
-1c), 56.402(C-2a),29.474, 18.475(C(CH3)2),16.687
(C-6c)
Compound [5] Rf = 0.43 (toluene / acetone = 2/1) [α] D 24 + 2.5 ° (C = 0.56, CHCl 3 ) Elemental analysis value: C 60 H 67 NO 16 · 1 / 2H 2 O = 1067.206 calculated C; 67.53 H; 6.42 N; 1.31 measurements C; 67.49 H; 6.39 N; 1.21 1 H-NMR (400MHz, CDCl 3) δ; 7.72-7.02
(m, 24H, aromatic H), 5.649 (m, 1H, -CH 2 - CH = C
H 2 ), 5.113 (d, 1H, H-1a, J = 8.5Hz), 5.070 (dd, 1H,
= CH 2 , J = 1.5, 17.1Hz), 4.983 (dd, 1H, = CH 2 , J = 1.
5, 10.4Hz), 4.833 (d, 1H, H-1c, J = 3.7Hz), 4.551
(d, 1H, H-1b, J = 7.6Hz), 1.392, 1.301 (2 × s, 6H,
= C (CH 3 ) 2 ), 1.098 (d, 3H, H-6c, J = 6.4 Hz) 13 C-NMR (CDCl 3 ) δ; 168.013 (C = O), 101.426
(C-1b), 98.718 ( = C (CH 3 ) 2 ), 97.686 (C-1a), 97.469 (C
-1c), 56.402 (C-2a), 29.474, 18.475 (C (CH 3 ) 2 ), 16.687
(C-6c)

【0034】〔参考例3〕(化合物〔6〕の合成) アルゴンガス雰囲気下、酸化銀3.01g(13mM)の
入ったフラスコに、化合物〔4〕2.65g(2.5mM)
及びベンジルブロマイド4.27g(25mM)を乾燥D
MF25mlに溶解して注入した。氷冷下、この反応溶液
に、ヨウ化カリウム2.16g(13mM)を加え、1時
間攪拌した。反応終了後、反応溶液を酢酸エチルで希釈
し、不溶物をセライトよりろ去し、ろ液を水、希塩酸、
飽和食塩水にて順次洗浄後、硫酸マグネシウムで乾燥
し、溶媒を留去した。残渣をカラムクロマトグラフィー
(トルエン/酢酸エチル=7/1 展開)にて精製し、油状
物2.72g(収率、87.9%)を得た。 Rf=0.59 (トルエン/酢酸エチル=6/1) 〔α〕D 27−2.2°(C=0.87、CHCl3) 元素分析値:C74H79NO16=1238.452として 計算値 C ; 71.77 H ; 6.43 N ; 1.13 測定値 C ; 71.80 H ; 6.43 N ; 1.131 H−NMR(400MHz、CDCl3 )δ;7.72-7.
01 (m,34H, アロマチックH),5.647 (m, 1H,-CH2-CH=CH
2), 5.134 (d, 1H, H-1a, J=8.5Hz), 5.069 (dd, 1H, =
CH2 , J=1.5, 17.1Hz), 4.983 (dd, 1H, =CH 2, J=1.5, 1
0.4Hz), 4.805 (d, 1H, H-1c, J=3.2Hz), 4.155 (t, 1
H, H-2a, J=9.5Hz), 3.528 (d, 1H, H-4c,J=1.5Hz), 1.
321, 1.293 (2× s, 6H, =C(CH3)2 ), 0.990 (d, 3H, H
-6c, J=6.4Hz)13 C−NMR(CDCl3 )δ;168.013 (C=0), 109.4
98(=C(CH3)2), 101.470(C-1b), 97.850 (C-1a), 97.469
(C-1c), 56.510 (C-2a), 28.011, 26.277 (=C(CH3)2),
16.849 (C-6c)
[Reference Example 3] (Synthesis of Compound [6]) In an argon gas atmosphere, a flask containing 3.01 g (13 mM) of silver oxide was charged with Compound [4] 2.65 g (2.5 mM).
And 4.27 g (25 mM) of benzyl bromide are dried D
It was dissolved in 25 ml of MF and injected. 2.16 g (13 mM) of potassium iodide was added to this reaction solution under ice cooling, and the mixture was stirred for 1 hour. After completion of the reaction, the reaction solution was diluted with ethyl acetate, the insoluble matter was filtered off from Celite, and the filtrate was diluted with water, diluted hydrochloric acid,
The organic layer was washed successively with saturated brine and dried over magnesium sulfate, and the solvent was distilled off. The residue was purified by column chromatography (toluene / ethyl acetate = 7/1 development) to obtain 2.72 g (yield, 87.9%) of an oily substance. Rf = 0.59 (toluene / ethyl acetate = 6/1) [α] D 27 −2.2 ° (C = 0.87, CHCl 3 ) Elemental analysis value: Calculated as C 74 H 79 NO 16 = 1238.452 C; 71.77 H; 6.43 N; 1.13 Measured value C; 71.80 H; 6.43 N; 1.13 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.72-7.
01 (m, 34H, aromatic H), 5.647 (m, 1H, -CH 2 - CH = CH
2 ), 5.134 (d, 1H, H-1a, J = 8.5Hz), 5.069 (dd, 1H, =
CH 2 , J = 1.5, 17.1Hz), 4.983 (dd, 1H, = CH 2 , J = 1.5, 1
0.4Hz), 4.805 (d, 1H, H-1c, J = 3.2Hz), 4.155 (t, 1
H, H-2a, J = 9.5Hz), 3.528 (d, 1H, H-4c, J = 1.5Hz), 1.
321, 1.293 (2 × s, 6H, = C (CH 3 ) 2 ), 0.990 (d, 3H, H
-6c, J = 6.4Hz) 13 C-NMR (CDCl 3 ) δ; 168.013 (C = 0), 109.4
98 (= C ( CH 3 ) 2 ), 101.470 (C-1b), 97.850 (C-1a), 97.469
(C-1c), 56.510 (C-2a), 28.011, 26.277 (= C (CH 3 ) 2 ),
16.849 (C-6c)

【0035】 〔参考例4〕(化合物〔7〕及び〔8〕の合成) 化合物〔6〕2.62g(2.11mM)をトリフルオロ酢
酸/THF/水(20ml/25ml/5ml)混合溶媒に溶
解し、氷冷下、4時間及び室温下2時間攪拌した。反応
溶液を酢酸エチルで抽出し、水、飽和重ソウ水、飽和食
塩水にて、順次洗浄後、硫酸マグネシウムにて乾燥し、
溶媒を留去した。残渣をカラムクロマトグラフィー(ト
ルエン/酢酸エチル=3/1展開)にて精製し、化合物
〔7〕517mg(収率、31.3%)及び化合物〔8〕1.
72g(収率、68.0%)を得た。 化合物〔7〕 Rf=0.08 (トルエン/酢酸エチル=3/1) 〔α〕D 27+6.3°(C=0.73、CHCl3) 元素分析値:C44H47NO12=781.866 として 計算値 C ; 67.59 H ; 6.06 N ; 1.79 測定値 C ; 67.60 H ; 6.10 N ; 1.631 H−NMR(400MHz、CDCl3 )δ;7.85-7.
16 (m,19H, アロマチックH), 5.739 (m, 1H,-CH2-CH=CH
2), 5.256 (d, 1H, H-1a, J=8.5Hz), 5.132 (dd, 1H, =
CH2 , J=1.5, 17.4Hz), 5.047 (dd, 1H, =CH 2, J=1.5, 1
0.4Hz), 4.340 (d, 1H, H-1b, J=7.3Hz), 4.289 (ddt,
1H, O-CH2 -CH=CH2, J=1.2, 4.9, 13.1Hz), 4.056 (ddt,
1H, O-CH 2CH=CH2, J=1.2, 6.4, 13.1Hz)13 C−NMR(CDCl3 )δ;103.537 (C-1b), 97.3
61 (C-1a), 56.239 (C-2a)
[Reference Example 4] (Synthesis of Compounds [7] and [8]) 2.62 g (2.11 mM) of Compound [6] was mixed with trifluoroacetic acid / THF / water (20 ml / 25 ml / 5 ml) mixed solvent. After dissolution, the mixture was stirred under ice cooling for 4 hours and at room temperature for 2 hours. The reaction solution was extracted with ethyl acetate, washed successively with water, saturated aqueous sodium hydrogen carbonate and saturated brine, and dried over magnesium sulfate.
The solvent was distilled off. The residue was purified by column chromatography (toluene / ethyl acetate = 3/1 development) to give 517 mg of compound [7] (yield, 31.3%) and compound [8] .1.
72 g (yield, 68.0%) was obtained. Compound [7] Rf = 0.08 (toluene / ethyl acetate = 3/1) [α] D 27 + 6.3 ° (C = 0.73, CHCl 3 ) Elemental analysis value: C 44 H 47 NO 12 = 781.866 Calculated value as C; 67.59 H; 6.06 N; 1.79 Measured value C; 67.60 H; 6.10 N; 1.63 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.85-7.
16 (m, 19H, aromatic H), 5.739 (m, 1H, -CH 2 - CH = CH
2 ), 5.256 (d, 1H, H-1a, J = 8.5Hz), 5.132 (dd, 1H, =
CH 2 ,, J = 1.5, 17.4Hz), 5.047 (dd, 1H, = CH 2 ,, J = 1.5, 1
0.4Hz), 4.340 (d, 1H, H-1b, J = 7.3Hz), 4.289 (ddt,
1H, O -CH 2 -CH = CH 2 , J = 1.2, 4.9, 13.1Hz), 4.056 (ddt,
1H, O- CH 2 CH = CH 2 , J = 1.2, 6.4, 13.1Hz) 13 C-NMR (CDCl 3 ) δ; 103.537 (C-1b), 97.3
61 (C-1a), 56.239 (C-2a)

【0036】化合物〔8〕 Rf=0.45 (トルエン/酢酸エチル=3/1) 〔α〕D 27−11.4°(C=0.76、CHCl3) 元素分析値:C71H75NO16=1198.386として 計算値 C ; 71.16 H ; 6.31 N ; 1.17 測定値 C ; 71.70 H ; 6.38 N ; 1.491 H−NMR(400MHz、CDCl3 )δ;7.72-7.
02 (m,34H, アロマチックH), 5.652 (m, 1H,-CH2-CH=CH
2), 5.162 (d, 1H, H-1a, J=8.5Hz), 5.074 (dd, 1H, =
CH2 , J=1.8, 17.4Hz), 4.986 (dd, 1H, =CH 2, J=1.5, 1
0.4Hz), 1.086 (d, 3H, H-6c, J=6.4Hz)13 C−NMR(CDCl3 )δ;168.013 (C=0), 101.6
95 (C-1b), 97.742 (C-1a), 97.469 (C-1c), 56.294 (C
-2a), 16.795 (C-6c)
Compound [8] Rf = 0.45 (toluene / ethyl acetate = 3/1) [α] D 27 -11.4 ° (C = 0.76, CHCl 3 ) Elemental analysis value: C 71 H 75 Calculated value with NO 16 = 1198.386 C; 71.16 H; 6.31 N; 1.17 Measured value C; 71.70 H; 6.38 N; 1.49 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.72-7.
02 (m, 34H, aromatic H), 5.652 (m, 1H, -CH 2 - CH = CH
2 ), 5.162 (d, 1H, H-1a, J = 8.5Hz), 5.074 (dd, 1H, =
CH 2 ,, J = 1.8, 17.4Hz), 4.986 (dd, 1H, = CH 2 ,, J = 1.5, 1
0.4Hz), 1.086 (d, 3H, H-6c, J = 6.4Hz) 13 C-NMR (CDCl 3 ) δ; 168.013 (C = 0), 101.6
95 (C-1b), 97.742 (C-1a), 97.469 (C-1c), 56.294 (C
-2a), 16.795 (C-6c)

【0037】〔参考例5〕(化合物Reference Example 5 (Compound

〔9〕の合成) 化合物〔8〕450mg(0.37mM)を無水酢酸/ピリ
ジン/4−ジメチルアミノピリジン12ml/2ml/触媒
量)に溶解し、室温にて、終夜攪拌した。反応溶液を酢
酸エチルで抽出し、水、飽和重ソウ水、希塩酸、飽和食
塩水にて、順次洗浄後、硫酸マグネシウムにて乾燥し、
溶媒を留去した。残渣をカラムクロマトグラフィー(ト
ルエン/酢酸エチル=6/1展開)にて精製して油状物
420mg(収率、87.3%)を得た。 Rf=0.66 (トルエン/酢酸エチル=5/1) 〔α〕D 26−7.9°(C=0.80、CHCl3) 元素分析値:C75H79NO18=1282.462として 計算値 C ; 70.24 H ; 6.21 N ; 1.09 測定値 C ; 70.27 H ; 6.22 N ; 0.981 H−NMR(400MHz、CDCl3 )δ;7.72-6.
99 (m,34H, アロマチックH), 5.639 (m, 1H,-CH2-CH=CH
2), 5.328 (d, 1H H-4b, J=2.7Hz), 5.109 (d,1H, H-1
a, J=8.5Hz), 5.065 (dd, 1H, =CH 2, J=1.5, 17.4Hz),
4.983 (dd, 1H,=CH2 , J=1.5, 10.4Hz), 4.826 (d, 1H,
H-1c, J=3.6Hz), 4.566 (d, 1H, H-1b,J=7.6Hz), 3.884
(dd, 1H, H-3c, J=2.7, 10.1Hz), 3.777 (dd, 1H, H-2
c, J=3.6, 10.1Hz), 3.519 (d, 1H, H-4c, J=3.1Hz),
1.911, 1.749 (2 ×S, 6H,COCH 3), 1.128 (d, 3H, H-6
C, J=6.4Hz),13 C−NMR(CDCl3 )δ;169.747, 169.530, 16
8.013 (C=0), 101.968 (C-1b), 97.794 (C-1a), 97.469
(C-1c), 56.402 (C-2a), 20.588 (COCH 3), 17.012 (C-
6c)
Synthesis of [9]] 450 mg (0.37 mM) of compound [8] was dissolved in acetic anhydride / pyridine / 4-dimethylaminopyridine 12 ml / 2 ml / catalyst amount), and the mixture was stirred overnight at room temperature. The reaction solution was extracted with ethyl acetate, washed successively with water, saturated sodium bicarbonate water, diluted hydrochloric acid, and saturated saline, and dried over magnesium sulfate,
The solvent was distilled off. The residue was purified by column chromatography (toluene / ethyl acetate = 6/1 development) to obtain 420 mg of an oily substance (yield, 87.3%). Rf = 0.66 (toluene / ethyl acetate = 5/1) [α] D 26 −7.9 ° (C = 0.80, CHCl 3 ) Elemental analysis value: Calculated as C 75 H 79 NO 18 = 1282.462 C; 70.24 H; 6.21 N; 1.09 Measured value C; 70.27 H; 6.22 N; 0.98 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.72-6.
99 (m, 34H, aromatic H), 5.639 (m, 1H, -CH 2 - CH = CH
2 ), 5.328 (d, 1H H-4b, J = 2.7Hz), 5.109 (d, 1H, H-1
a, J = 8.5Hz), 5.065 (dd, 1H, = CH 2 , J = 1.5, 17.4Hz),
4.983 (dd, 1H, = CH 2 , J = 1.5, 10.4Hz), 4.826 (d, 1H,
H-1c, J = 3.6Hz), 4.566 (d, 1H, H-1b, J = 7.6Hz), 3.884
(dd, 1H, H-3c, J = 2.7, 10.1Hz), 3.777 (dd, 1H, H-2
c, J = 3.6, 10.1Hz), 3.519 (d, 1H, H-4c, J = 3.1Hz),
1.911, 1.749 (2 × S, 6H, CO CH 3 ), 1.128 (d, 3H, H-6
C, J = 6.4 Hz), 13 C-NMR (CDCl 3 ) δ; 169.747, 169.530, 16
8.013 (C = 0), 101.968 (C-1b), 97.794 (C-1a), 97.469
(C-1c), 56.402 (C-2a), 20.588 (CO CH 3 ), 17.012 (C-
6c)

【0038】〔参考例6〕(化合物〔10〕の合成) 化合物Reference Example 6 (Synthesis of Compound [10]) Compound

〔9〕405mg(0.316mM)、塩化パラジウ
ム265mg(1.5mM)及び酢酸ナトリウム123mg
(1.5mM)を、90%酢酸に溶解し、室温にて、4時
間攪拌した。反応溶液を酢酸エチルで希釈し、不溶物を
セライトよりろ去し、ろ液を水、飽和重ソウ水、飽和食
塩水にて順次洗浄後、硫酸マグネシウムにて乾燥後、溶
媒を留去した。残渣をカラムクロマトグラフィー(トル
エン/酢酸エチル=5/1展開)にて精製し、油状物2
78mg(収率、70.9%)を得た。 Rf=0.58 (トルエン/酢酸エチル=2/1) 〔α〕D 27+1.6°(C=0.84、CHCl3) 元素分析値:C72H75NO18=1242.396として 計算値 C ; 69.61 H ; 6.08 N ; 1.13 測定値 C ; 69.40 H ; 6.09 N ; 1.041 H−NMR(400MHz、CDCl3 )δ;7.71-6.
89 (m,34H, アロマチックH), 5.324 (d, 1H, H-4b, J=
2.7Hz), 4.830 (d, 1H, H-1c, J=3.6Hz), 3.877(dd, 1
H, H-3c, J=2.7, 10.1Hz), 3.784 (dd, 1H, H-2c, J=3.
6, 10.4Hz), 1.917, 1.745 (2 ×S, 6H, COCH3), 1.135
(d, 3H, H-6c, J=6.4Hz)
[9] 405 mg (0.316 mM), palladium chloride 265 mg (1.5 mM) and sodium acetate 123 mg
(1.5 mM) was dissolved in 90% acetic acid and stirred at room temperature for 4 hours. The reaction solution was diluted with ethyl acetate, the insoluble matter was filtered off from Celite, the filtrate was washed successively with water, saturated aqueous sodium bicarbonate solution and saturated brine, dried over magnesium sulfate, and the solvent was evaporated. The residue was purified by column chromatography (toluene / ethyl acetate = 5/1 development) to give an oil 2
78 mg (yield, 70.9%) were obtained. Rf = 0.58 (toluene / ethyl acetate = 2/1) [α] D 27 + 1.6 ° (C = 0.84, CHCl 3 ) Elemental analysis value: C 72 H 75 NO 18 = 1242.396 Calculated value C 69.61 H; 6.08 N; 1.13 Measured value C; 69.40 H; 6.09 N; 1.04 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.71-6.
89 (m, 34H, Aromatic H), 5.324 (d, 1H, H-4b, J =
2.7Hz), 4.830 (d, 1H, H-1c, J = 3.6Hz), 3.877 (dd, 1
H, H-3c, J = 2.7, 10.1Hz), 3.784 (dd, 1H, H-2c, J = 3.
6, 10.4Hz), 1.917, 1.745 (2 × S, 6H, COCH 3 ), 1.135
(d, 3H, H-6c, J = 6.4Hz)

【0039】〔参考例7〕(化合物〔11〕の合成) アルゴンガス雰囲気下、化合物〔10〕232mg(0.1
86mM)及びトリクロロアセトニトリル288mg(2
mM)をジクロロメタン5mlに溶解し、これに、氷冷
下、DBU30μl (0.2mM)を注入し、1時間攪拌
した。反応溶液を直接カラムクロマトグラフィー(トル
エン/酢酸エチル=5/1展開)にて精製し、油状物2
08mg(収率、81.2%)を得た。 Rf=0.46 (トルエン/酢酸エチル=5/1) 〔α〕D 27+6.5°(C=1.0、CHCl3)1 H−NMR(400MHz、CDCl3 )δ;8.528
(s, 1H, NH), 7.69-6.99(m,34H,アロマチックH), 6.394
(d, 1H, H-1a, J=8.8Hz), 5.328 (d, 1H, H-4b, J=2.9
Hz), 4.828 (d, 1H, H-1c, J=3.6Hz), 4.627 (d, 1H, H
-1b, J=8.0Hz),3.885 (d, d, 1H, H-3c, J=2.4, 10.2H
z), 3.786 (dd, 1H, H-2c, J=3.6, 10.2Hz), 1.915, 1.
759 (2 ×S, 6H, COCH3), 1.300 (d, 3H, H-6c, J=6.6H
z)
Reference Example 7 (Synthesis of Compound [11]) 232 mg of Compound [10] (0.1) under an argon gas atmosphere.
86 mM) and 288 mg of trichloroacetonitrile (2
(mM) was dissolved in 5 ml of dichloromethane, and 30 μl (0.2 mM) of DBU was added thereto under ice cooling and stirred for 1 hour. The reaction solution was directly purified by column chromatography (toluene / ethyl acetate = 5/1 development) to give oil 2
08 mg (yield, 81.2%) was obtained. Rf = 0.46 (toluene / ethyl acetate = 5/1) [α] D 27 + 6.5 ° (C = 1.0, CHCl 3 ) 1 H-NMR (400 MHz, CDCl 3 ) δ; 8.528
(s, 1H, NH), 7.69-6.99 (m, 34H, aromatic H), 6.394
(d, 1H, H-1a, J = 8.8Hz), 5.328 (d, 1H, H-4b, J = 2.9
Hz), 4.828 (d, 1H, H-1c, J = 3.6Hz), 4.627 (d, 1H, H
-1b, J = 8.0Hz), 3.885 (d, d, 1H, H-3c, J = 2.4, 10.2H
z), 3.786 (dd, 1H, H-2c, J = 3.6, 10.2Hz), 1.915, 1.
759 (2 × S, 6H, COCH 3 ), 1.300 (d, 3H, H-6c, J = 6.6H
z)

【0040】 〔参考例8〕(化合物〔13〕及び〔14〕の合成) アルゴンガス雰囲気下、事前に十分乾燥したM.S.(A.W.
400)1.5gの入った二径褐色フラスコに化合物〔1
1〕578mg(0.42mM)及び〔12〕605mg(0.
62mM)をジクロロエタン15mlに溶解し加えた。−
23℃(CCl4−ドライアイス)下、 BF3・Et2O 50μ
l (0.42mM)を加え、1時間攪拌した。トリエチル
アミンを加え、反応を終了後、クロロホルムで希釈し、
不溶物をセライトよりろ去し、ろ液を水、飽和重ソウ
水、飽和食塩水にて順次洗浄し、硫酸マグネシウムで乾
燥後、溶媒を留去した。残渣をカラムクロマトグラフィ
ー(n−ヘキサン/酢酸エチル=5/1展開)にて精製
し、化合物〔13〕472mg(収率、51.1%)及び化
合物〔14〕90mg(収率、17.5%)を得、化合物
〔12〕372mg(収率、61.5%)を回収した。
[Reference Example 8] (Synthesis of Compounds [13] and [14]) MS (AW) sufficiently dried in advance under an argon gas atmosphere.
400) Compound [1
1] 578 mg (0.42 mM) and [12] 605 mg (0.4
62 mM) was dissolved in 15 ml of dichloroethane and added. −
BF 3 · Et 2 O 50μ under 23 ℃ (CCl 4 -Dry ice)
1 (0.42 mM) was added and stirred for 1 hour. Triethylamine was added, and after the reaction was completed, it was diluted with chloroform,
The insoluble matter was filtered off from Celite, and the filtrate was washed successively with water, saturated sodium bicarbonate water and saturated saline, dried over magnesium sulfate, and then the solvent was distilled off. The residue was purified by column chromatography (n-hexane / ethyl acetate = 5/1 development) to obtain 472 mg of compound [13] (yield, 51.1%) and 90 mg of compound [14] (yield, 17.5%). %), And 372 mg of the compound [12] (yield, 61.5%) was recovered.

【0041】化合物〔13〕 Rf=0.40 (n−ヘキサン/酢酸エチル=2/1) 〔α〕D 27−23.5°(C=0.52、CHCl3) 元素分析値:C133H137NO28=2197.564 計算値 C ; 72.69 H ; 6.28 N ; 0.64 測定値 C ; 72.22 H ; 6.24 N ; 0.701 H−NMR(400MHz、CDCl3 )δ;7.38-6.
84 (m,69H, アロマチックH), 5.351 (d, 1H, H-4d, J=
3.6Hz), 5.345 (d, 1H, H-1c, J=8.2Hz), 1.926,1.740
(2 ×S, 6H,COCH 3), 1.131 (d, 3H, H-6e, J=6.7Hz)13 C−NMR(CDCl3 )δ;169.695, 169.478, 16
7.632 (C=0), 102.454 (C-1a, C-1b), 102.020 (C-1d),
99.961 (C-1c), 97.577 (C-1e), 57.106 (C-2c), 20.5
34 (COCH 3), 16.958 (C-6e)
The compound [13] Rf = 0.40 (n-hexane / ethyl acetate = 2/1) [α] D 27 -23.5 ° (C = 0.52 , CHCl 3) Elemental analysis: C 133 H 137 NO 28 = 2197.564 Calculated value C; 72.69 H; 6.28 N; 0.64 Measured value C; 72.22 H; 6.24 N; 0.70 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.38-6.
84 (m, 69H, aromatic H), 5.351 (d, 1H, H-4d, J =
3.6Hz), 5.345 (d, 1H, H-1c, J = 8.2Hz), 1.926,1.740
(2 × S, 6H, CO CH 3 ), 1.131 (d, 3H, H-6e, J = 6.7 Hz) 13 C-NMR (CDCl 3 ) δ; 169.695, 169.478, 16
7.632 (C = 0), 102.454 (C-1a, C-1b), 102.020 (C-1d),
99.961 (C-1c), 97.577 (C-1e), 57.106 (C-2c), 20.5
34 (CO CH 3 ), 16.958 (C-6e)

【0042】化合物〔14〕 Rf=0.29 (n−ヘキサン/酢酸エチル) 〔α〕D 24−41.4°(C=0.69、CHCl3) 元素分析値:C72H74NO17=1225.389として 計算値 C ; 70.57 H ; 6.09 N ; 1.14 測定値 C ; 70.63 H ; 6.03 N ; 1.081 H−NMR(400MHz、CDCl3 )δ;7.72-7.
04 (m,34H, アロマチックH), 6.714 (s, 1H, H-1a), 5.
439 (d, 1H, H-4b, J=2.7Hz), 4.955 (dd, 1H,H-3b, J=
3.6, 10.4Hz), 4.797 (d, 1H, H-1c, J=3.4Hz), 3.380
(d, 1H, H-4c,J=1.5Hz), 2.039, 1.952 (2 ×S, 6H, CO
CH3), 0.836 (d, 3H, H-6c, J=6.7Hz)13C−NMR(C
DCl3 )δ; 170.015, 169.851, 168.013 (C=0), 10
7.655(C-1a), 102.779 (C-1b), 98.661 (C-1c), 20.642
(COCH 3), 16.525 (C-6c)
Compound [14] Rf = 0.29 (n-hexane / ethyl acetate) [α] D 24 -41.4 ° (C = 0.69, CHCl 3 ) Elemental analysis value: C 72 H 74 NO 17 = 1225.389 calculated value C; 70.57 H; 6.09 N; 1.14 measured value C; 70.63 H; 6.03 N; 1.08 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.72-7.
04 (m, 34H, Aromatic H), 6.714 (s, 1H, H-1a), 5.
439 (d, 1H, H-4b, J = 2.7Hz), 4.955 (dd, 1H, H-3b, J =
3.6, 10.4Hz), 4.797 (d, 1H, H-1c, J = 3.4Hz), 3.380
(d, 1H, H-4c, J = 1.5Hz), 2.039, 1.952 (2 × S, 6H, CO
CH 3 ), 0.836 (d, 3H, H-6c, J = 6.7Hz) 13 C-NMR (C
DCl 3 ) δ; 170.015, 169.851, 168.013 (C = 0), 10
7.655 (C-1a), 102.779 (C-1b), 98.661 (C-1c), 20.642
(CO CH 3 ), 16.525 (C-6c)

【0043】〔参考例9〕(化合物〔15〕の合成) 化合物〔13〕446mg(0.203mM)をメタノール
/THF(10ml/4ml)に溶解し、これに、0.2N N
aOMeメタノール溶液2mlを加え、室温にて、2時間攪拌
した。反応終了後、アンバーリスト15を加え、反応溶
液を中和後、ろ去し、ろ液を留去した。残渣をカラムク
ロマトグラフィー(トルエン/酢酸エチル=5/1展
開)にて精製し、油状物374mg(収率、87.2%)を
得た。 Rf=0.46 (トルエン/酢酸エチル=3/1) 〔α〕D 25−21.6°(C=0.69、CHCl3 ) 元素分析値: C129H133NO26 =2113.488 として 計算値 C ; 73.31 H ; 6.34 N ; 0.66 測定値 C ; 73.42 H ; 6.38 N ; 0.701 H−NMR(400MHz、CDCl3 )δ;7.52-7.
00 ( m, 69H, アロマチックH), 5.400 (d,1H,H-1c,J=8.
5Hz), 1.087 (d,3H,H-6e,J=6.4Hz)13 C−NMR(CDCl3 )δ;167.683 (C=0), 102.
454 (C-1a,C-1b), 101.804 (C-1d), 99.961 (C-1c), 9
7.742 (C-1e), 57.052 (C-2c), 16.904 (C-6e),
[Reference Example 9] (Synthesis of compound [15]) 446 mg (0.203 mM) of compound [13] was dissolved in methanol / THF (10 ml / 4 ml), and 0.2 N N was added thereto.
2 ml of aOMe methanol solution was added, and the mixture was stirred at room temperature for 2 hours. After completion of the reaction, Amberlyst 15 was added to neutralize the reaction solution, which was then filtered off, and the filtrate was evaporated. The residue was purified by column chromatography (toluene / ethyl acetate = 5/1 development) to obtain 374 mg of an oily substance (yield, 87.2%). Rf = 0.46 (toluene / ethyl acetate = 3/1) [α] D 25 -21.6 ° (C = 0.69 , CHCl 3) Elemental analysis: Calculated C 129 H 133 NO 26 = 2113.488 C; 73.31 H; 6.34 N; 0.66 measured value C; 73.42 H; 6.38 N; 0.70 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.52-7.
00 (m, 69H, aromatic H), 5.400 (d, 1H, H-1c, J = 8.
5Hz), 1.087 (d, 3H, H-6e, J = 6.4Hz) 13 C-NMR (CDCl 3 ) δ; 167.683 (C = 0), 102.
454 (C-1a, C-1b), 101.804 (C-1d), 99.961 (C-1c), 9
7.742 (C-1e), 57.052 (C-2c), 16.904 (C-6e),

【0044】 〔実施例1〕(化合物〔17〕及び〔18〕の合成) アルゴンガス雰囲気下、事前に十分乾燥した M.S.(A.W.
400)500mgの入った二径褐色フラスコに化合物
〔15〕211mg(0.1mM)及び〔16〕182mg
(0.14mM)をジクロロエタン7mlに溶解し加えた。
−23℃(四塩化炭素/ドライアイス)下、BF3 ・ Et2O
12μl(0.1mM)を加え、1時間撹拌した。トリ
エチルアミンを加え、反応を終了後、クロロホルムで希
釈し、不溶物をセライトよりろ去し、ろ液を飽和重ソウ
水、飽和食塩水にて順次洗浄後、硫酸マグネシウムで乾
燥し、溶媒を留去した。残渣をゲルろ過法(Bio-boads S
-X2、日本バイオラッドラボラトリーズ、ベンゼン展
開)及びカラムクロマトグラフィー(トルエン/酢酸エ
チル=4/1 展開)にて精製し、化合物〔17〕252mg
(収率、77.8%)、化合物〔18〕20.0mg(収率、
12.0%)及び化合物〔15〕14mg(収率、6.6%)
を回収した。
Example 1 (Synthesis of Compounds [17] and [18]) MS (AW) which was sufficiently dried in advance under an argon gas atmosphere.
400) 500 mg in a 2 diameter brown flask containing compound [15] 211 mg (0.1 mM) and [16] 182 mg
(0.14 mM) was dissolved in 7 ml of dichloroethane and added.
-23 ° C (carbon tetrachloride / dry ice), BF 3 · Et 2 O
12 μl (0.1 mM) was added and stirred for 1 hour. Triethylamine was added and after the reaction was completed, the reaction mixture was diluted with chloroform, the insoluble matter was removed by filtration from Celite, the filtrate was washed successively with saturated aqueous sodium bicarbonate solution and saturated brine, dried over magnesium sulfate, and the solvent was distilled off. did. The residue was subjected to gel filtration (Bio-boads S
-X2, Nippon Bio-Rad Laboratories, developed with benzene) and column chromatography (developed with toluene / ethyl acetate = 4/1), compound [17] 252 mg
(Yield, 77.8%), Compound [18] 20.0 mg (Yield,
12.0%) and 14 mg of compound [15] (yield, 6.6%)
Was recovered.

【0045】化合物〔17〕 Rf=0.72 (トルエン/酢酸エチル) 〔α〕D 26 27.4°(C=0.92、CHCl3 ) 元素分析値: C191H198N2O45 ・ H2O=3259.707 として 計算値 C ; 70.38 H ; 6.18 N ; 0.86 測定値 C ; 70.07 H ; 6.09 N ; 0.961 H−NMR(400MHz、CDCl3 )δ;7.41-6.
79 ( m, 93H, アロマチックH), 5.316 (d,1H,H-1f,J=8.
3Hz), 5.236 (d,1H,H-4h,J=2.7Hz), 5.148 (d,1H,H-1c,
J=8.3Hz), 5.008 (dd,1H,H-2h,J=8.3,10.3Hz), 1.999,
1.982, 1.947, 1.824 (4× S,12H,COCH3), 1.194 (d,3
H,H-6g,J=6.4Hz), 0.999 (d,3H,H-6e,J=6.4Hz)13 C−NMR(CDCl3 )δ;169.851, 169,634, 16
8,446, 167,849(C=0),102.402, 101.643, 99.961, 99.
584, 98.934, 97.469 (C-1a-h), 57.106, 56.510 (C-2
c,f), 21.347, 20.371 (COCH 3), 16.687 (C-6e, g)
Compound [17] Rf = 0.72 (toluene / ethyl acetate) [α] D 26 27.4 ° (C = 0.92, CHCl 3 ) Elemental analysis value: C 191 H 198 N 2 O 45. Calculated value with H 2 O = 3259.707 C; 70.38 H; 6.18 N; 0.86 Measured value C; 70.07 H; 6.09 N; 0.96 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.41-6.
79 (m, 93H, aromatic H), 5.316 (d, 1H, H-1f, J = 8.
3Hz), 5.236 (d, 1H, H-4h, J = 2.7Hz), 5.148 (d, 1H, H-1c,
J = 8.3Hz), 5.008 (dd, 1H, H-2h, J = 8.3,10.3Hz), 1.999,
1.982, 1.947, 1.824 (4 × S, 12H, COCH 3 ), 1.194 (d, 3
H, H-6g, J = 6.4Hz), 0.999 (d, 3H, H-6e, J = 6.4Hz) 13 C-NMR (CDCl 3 ) δ; 169.851, 169,634, 16
8,446, 167,849 (C = 0), 102.402, 101.643, 99.961, 99.
584, 98.934, 97.469 (C-1a-h), 57.106, 56.510 (C-2
c, f), 21.347, 20.371 (CO CH 3 ), 16.687 (C-6e, g)

【0046】化合物〔18〕 Rf=0.40 (トルエン/酢酸エチル) 〔α〕D 24−36.9°(C=0.51、CHCl3 ) 元素分析値: C62H65NO19 : 1/2H2O=1137.212 計算値 C ; 65.48 H ; 5.85 N ; 1.23 測定値 C ; 65.10 H ; 5.79 N ; 1.231 H−NMR(400MHz、CDCl3 )δ;7.73-7.
04 ( m, 24H, アロマチックH), 6.686 (s,1H,H-1a), 5.
372(d,1H,H-4b,J=2.4Hz), 5.259 (dd,1H,H-2b,J=8.2,1
0.7Hz), 4.984 (dd,1H,H-3b,J=3.3,10.7Hz), 4.824 (d,
1H,H-1c,J=3.0Hz),4.713,(d,1H,H-1b,J=7.9Hz), 3.747
(q,1H,H-5c,J=6.1Hz), 3.390 (d,1H,H-4c,J=1.5Hz), 2.
163, 2.064, 1.988, 1.924, ( 4× S,12H,COCH3), 0.8
43 (d,3H,H-6c,J=6.4Hz)
The compound [18] Rf = 0.40 (toluene / ethyl acetate) [α] D 24 -36.9 ° (C = 0.51 , CHCl 3) Elemental analysis: C 62 H 65 NO 19: 1 / 2H 2 O = 1137.212 calculated C; 65.48 H; 5.85 N; 1.23 measurements C; 65.10 H; 5.79 N; 1.23 1 H-NMR (400MHz, CDCl 3) δ; 7.73-7.
04 (m, 24H, aromatic H), 6.686 (s, 1H, H-1a), 5.
372 (d, 1H, H-4b, J = 2.4Hz), 5.259 (dd, 1H, H-2b, J = 8.2,1
0.7Hz), 4.984 (dd, 1H, H-3b, J = 3.3,10.7Hz), 4.824 (d,
1H, H-1c, J = 3.0Hz), 4.713, (d, 1H, H-1b, J = 7.9Hz), 3.747
(q, 1H, H-5c, J = 6.1Hz), 3.390 (d, 1H, H-4c, J = 1.5Hz), 2.
163, 2.064, 1.988, 1.924, (4 × S, 12H, COCH 3 ), 0.8
43 (d, 3H, H-6c, J = 6.4Hz)

【0047】〔実施例2〕(化合物〔19〕の合成) 化合物〔17〕252mg(0.077mM)を2%ヒドラ
ジン−エタノール20mlに溶解し、終夜還流撹拌した。
溶媒を留去し、残渣を無水酢酸/ピリジン/4−ジメチ
ルアミノピリジン(2ml/2ml/触媒量)に溶解し、室
温にて6時間撹拌した。反応終了後、反応溶液を酢酸エ
チルで抽出し、水、飽和重ソウ水、希塩酸、飽和食塩水
て順次洗浄後、硫酸マグネシウムで乾燥し、溶媒を留去
した。残渣をカラムクロマトグラフィー(酢酸エチル/
トルエン=1/1展開)にて精製し、油状物208mg
(収率、86.3%)を得た。 Rf=0.43 (酢酸エチル/トルエン=1/1) 〔α〕D 25−30.9°(C=1.1、CHCl3 ) 元素分析値: C181H198N2O44 ・ H2O=3123.567 として 計算値 C ; 69.60 H ; 6.45 N ; 0.89 測定値 C ; 69.27 H ; 6.43 N ; 0.841 H−NMR(400MHz、CDCl3 )δ;7.42-7.
06 ( m, 85H, アロマチックH), 5.501 (d,1H,NH), 5.44
7(d,1H,H-4d,J=3.3Hz), 5.419 (d,1H,NH), 5.278(d,1H,
H-4h,J=3.0Hz), 2.019, 1.947, 1.934, 1.862, 1.832,
1.469, 1.266, (7× S,21H,COCH3), 1.170 (d,3H,H-H-
6 e 又は g , J=6.4Hz), 1.114 (d,3H8,H-6 g 又は e
,J=6.4Hz)13 C−NMR(CDCl3 )δ;169.747, 169.366, 16
8.828 (C=0), 102.454,101.102, 99.745, 97.469, 96.
819 (C-1a-h), 59.111, 56.889 (C-2c,f) , 22.972, 2
1.401, 20.859, 20.534 (COCH3), 17.121, 16.741(C-6
e, g)
Example 2 (Synthesis of Compound [19]) 252 mg (0.077 mM) of compound [17] was dissolved in 20 ml of 2% hydrazine-ethanol, and the mixture was refluxed and stirred overnight.
The solvent was evaporated, the residue was dissolved in acetic anhydride / pyridine / 4-dimethylaminopyridine (2 ml / 2 ml / catalytic amount), and the mixture was stirred at room temperature for 6 hours. After completion of the reaction, the reaction solution was extracted with ethyl acetate, washed successively with water, saturated sodium bicarbonate water, dilute hydrochloric acid and saturated brine, dried over magnesium sulfate, and the solvent was evaporated. Column chromatography of the residue (ethyl acetate /
Purified with toluene = 1/1 development), 208 mg oil
(Yield, 86.3%) was obtained. Rf = 0.43 (ethyl acetate / toluene = 1/1) [α] D 25 -30.9 ° (C = 1.1 , CHCl 3) Elemental analysis: C 181 H 198 N 2 O 44 · H 2 Calculated value as O = 3123.567 C; 69.60 H; 6.45 N; 0.89 Measured value C; 69.27 H; 6.43 N; 0.84 1 H-NMR (400 MHz, CDCl 3 ) δ; 7.42-7.
06 (m, 85H, aromatic H), 5.501 (d, 1H, NH), 5.44
7 (d, 1H, H-4d, J = 3.3Hz), 5.419 (d, 1H, NH), 5.278 (d, 1H,
H-4h, J = 3.0Hz), 2.019, 1.947, 1.934, 1.862, 1.832,
1.469, 1.266, (7 × S, 21H, COCH 3 ), 1.170 (d, 3H, HH-
6 e or g , J = 6.4 Hz), 1.114 (d, 3H8, H-6 g or e
, J = 6.4 Hz) 13 C-NMR (CDCl 3 ) δ; 169.747, 169.366, 16
8.828 (C = 0), 102.454, 101.102, 99.745, 97.469, 96.
819 (C-1a-h), 59.111, 56.889 (C-2c, f), 22.972, 2
1.401, 20.859, 20.534 (C OC H 3 ), 17.121, 16.741 (C-6
e, g)

【0048】〔実施例3〕(化合物〔20〕の合成) 水素ガス雰囲気下、化合物〔19〕203mg(0.065
mM)及び10%Pd-C50 mg のメタノール酢酸(3ml
/3ml)溶液を室温にて終夜撹拌した。反応終了後、触
媒をろ去し、溶媒を留去後、残渣を無水酢酸/ピリジン
/4−DMAP(2ml/2ml/触媒量)に溶解し、室温
にて終夜撹拌した。反応溶液を酢酸エチルで抽出し、
水、飽和重ソウ水、希塩酸、飽和食塩水にて順次洗浄
後、硫酸マグネシウムで乾燥し、溶媒を留去した。残渣
をカラムクロマトグラフィー(アセトン/トルエン=1
/1展開)にて精製し、油状物117mg(収率、78.0
%)を得た。 Rf=0.43 (アセトン/トルエン=2/1) 元素分析値: C96H132N2O61 =2290.098 計算値 C ; 50.35 H ; 5.81 N ; 1.22 測定値 C ; 49.98 H ; 5.75 N ; 1.281 H−NMR(400MHz、CDCl3 )δ;6.254
(d,1H,H-1aα, J=3.7Hz), 2.191-1.966 (mS, 72H, COCH
3), 1.203, 1.156, ( 2×d,2× 3H, H-6e, gJ=6.4H
z)
[Example 3] (Synthesis of compound [20]) 203 mg (0.065) of compound [19] was prepared under a hydrogen gas atmosphere.
mM) and 10% Pd-C 50 mg methanol acetic acid (3 ml
The solution was stirred overnight at room temperature. After completion of the reaction, the catalyst was filtered off, the solvent was distilled off, the residue was dissolved in acetic anhydride / pyridine / 4-DMAP (2 ml / 2 ml / catalyst amount), and the mixture was stirred at room temperature overnight. The reaction solution is extracted with ethyl acetate,
The extract was washed successively with water, saturated sodium bicarbonate water, diluted hydrochloric acid, and saturated brine, dried over magnesium sulfate, and the solvent was evaporated. Column chromatography of the residue (acetone / toluene = 1
1/1 development), 117 mg of oily matter (yield, 78.0
%) Was obtained. Rf = 0.43 (acetone / toluene = 2/1) Elemental analysis value: C 96 H 132 N 2 O 61 = 2290.098 Calculated value C; 50.35 H; 5.81 N; 1.22 Measured value C; 49.98 H; 5.75 N; 1.28 1 H-NMR (400 MHz, CDCl 3 ) δ; 6.254
(d, 1H, H-1aα, J = 3.7Hz), 2.191-1.966 (mS, 72H, COCH
3 ), 1.203, 1.156, (2 × d, 2 × 3H, H-6e, gJ = 6.4H
z)

【0049】〔実施例4〕(化合物〔21〕の合成) 化合物〔20〕103mg(0.045mM)をDMF2ml
に溶解し、これにヒドラジン・酢酸塩9.2mg(0.1m
M)を加え、室温にて1時間撹拌した。反応溶液を酢酸
エチルで抽出し、水洗後、硫酸マグネシウムで乾燥し、
溶媒を留去した。残渣をジクロロエタン1mlに溶解し、
これにトリクロロアセトニトリル72mg(0.5mM)を
加えた。アルゴンガス雰囲気、氷冷下、これに DBU 7
μl(0.045mM)を注入し、1時間撹拌した。反応
溶液を直接カラムクロマトグラフィー(アセトン/トル
エン=1/1展開)にて精製し、化合物〔21〕78mg
(収率、72.5%)を得た。 Rf=0.50 (アセトン/トルエン=3/2) 〔α〕D 25−25.0°(C=1.00、CHCl31 H−NMR(400MHz、CDCl3 )δ;8.651
( s, 1H, =NH), 6.482 (d,1H,H-1a, J=3.7Hz), 2.189-
1.901(ms, 69H, COCH3), 1.200, 1.153, ( 2×d,2×3
H, H-6e, g, J=6.6Hz)
[Example 4] (Synthesis of compound [21]) 103 mg (0.045 mM) of compound [20] was added to 2 ml of DMF.
Hydrazine acetate 9.2mg (0.1m
M) was added and the mixture was stirred at room temperature for 1 hour. The reaction solution was extracted with ethyl acetate, washed with water, dried over magnesium sulfate,
The solvent was distilled off. Dissolve the residue in 1 ml of dichloroethane,
To this was added 72 mg (0.5 mM) of trichloroacetonitrile. Argon gas atmosphere, under ice cooling, DBU 7
μl (0.045 mM) was injected and stirred for 1 hour. The reaction solution was directly purified by column chromatography (acetone / toluene = 1/1 development), and the compound [21] 78 mg
(Yield, 72.5%) was obtained. Rf = 0.50 (acetone / toluene = 3/2) [α] D 25 -25.0 ° (C = 1.00 , CHCl 3) 1 H-NMR (400MHz, CDCl 3) δ; 8.651
(s, 1H, = NH), 6.482 (d, 1H, H-1a, J = 3.7Hz), 2.189-
1.901 (ms, 69H, COCH 3 ), 1.200, 1.153, (2 × d, 2 × 3
(H, H-6e, g, J = 6.6Hz)

【0050】 〔参考例10〕(化合物〔23〕及び〔24〕の合成) アルゴンガス雰囲気下、事前に十分乾燥した M.S.(A.W.
300)300mgの入った二径褐色フラスコに化合物
〔21〕24.0mg(0.1mM)及び〔22〕9.0mg(0.
01mM)をクロロホルム2mlに溶解し加えた。−23
℃(CCl4 −ドライアイス)下、BF3 ・ Et2O 2μl(0.
015mM)を注入し、1時間撹拌した。トリエチルア
ミンを加え、反応を終了後、クロロホルムで希釈し、不
溶物をセライトよりろ去し、ろ液を飽和重ソウ水、飽和
食塩水にて順次洗浄し、硫酸マグネシウムで乾燥後、溶
媒を留去した。残渣をカラムクロマトグラフィー(トル
エン/アセトン=3/1展開)及びゲルろ過法(Bio-boa
ds S-X2 、日本バイオラッドラボラトリーズ、ベンゼン
展開)にて精製し、化合物〔23〕1.5mg(収率、4.8
%)及び〔24〕6.5mg(収率、27.2%)を得た。
[Reference Example 10] (Synthesis of Compounds [23] and [24]) MS (AW) thoroughly dried in advance under an argon gas atmosphere.
300) 300 mg in a 2 diameter brown flask containing compounds [21] 24.0 mg (0.1 mM) and [22] 9.0 mg (0.1 mM).
(01 mM) was dissolved in 2 ml of chloroform and added. -23
° C. (CCl 4 - dry ice) under, BF 3 · Et 2 O 2μl (0.
(015 mM) was injected and stirred for 1 hour. Triethylamine was added, and after the reaction was completed, the reaction mixture was diluted with chloroform, the insoluble matter was filtered off from Celite, the filtrate was washed successively with saturated aqueous sodium bicarbonate solution and saturated brine, dried over magnesium sulfate, and the solvent was distilled off. did. The residue was subjected to column chromatography (toluene / acetone = 3/1 development) and gel filtration method (Bio-boa
Purified by ds S-X2, Nippon Bio-Rad Laboratories, developed with benzene), and compound [23] 1.5 mg (yield, 4.8)
%) And [24] 6.5 mg (yield 27.2%).

【0051】化合物〔23〕 Rf=0.65 (トルエン/アセトン=1/1) 〔α〕D 24−29.3°(C=0.058、 CHCl31 H−NMR(400MHz、CDCl3 )δ;7.67-7.
30 ( m, 10H, アロマチックH), 2.188-1.900 (ms, 69H,
COCH3), 1.202 (d,3H,H-6 e 又は g , J=6.7Hz), 1.15
5 (d,3H,H-6 g 又は e , J=6.4Hz), 1.004 (s, 9H, -
tBu), 0.881 ( 2× t, 6H, 2 × CH3(Cer), J=5.5Hz) 化合物〔24〕 Rf=0.36 (アセトン/トルエン=1/1) 〔α〕D 25−47.0°(C=0.67、CHCl3 ) 元素分析値: C96H134N2O60 ・2H2O=2312.146として 計算値 C ; 49.87 H ; 6.01 N ; 1.21 測定値 C ; 49.55 H ; 5.79 N ; 1.231 H−NMR(400MHz、CDCl3 )δ;2.192-
1.902 ( ms,69H, COCH3), 1.203, 1.154, ( 2×d,2
× 3H, H-6e, g, J=6.7Hz)
The compound [23] Rf = 0.65 (toluene / acetone = 1/1) [α] D 24 -29.3 ° (C = 0.058 , CHCl 3) 1 H-NMR (400MHz, CDCl 3) δ ; 7.67-7.
30 (m, 10H, aromatic H), 2.188-1.900 (ms, 69H,
COCH 3 ), 1.202 (d, 3H, H-6 e or g , J = 6.7Hz), 1.15
5 (d, 3H, H-6 g or e , J = 6.4Hz), 1.004 (s, 9H,-
tBu), 0.881 (2 × t, 6H, 2 × CH 3 (Cer), J = 5.5Hz) Compound [24] Rf = 0.36 (acetone / toluene = 1/1) [α] D 25 -47. 0 ° (C = 0.67, CHCl 3 ) Elemental analysis value: Calculated value as C 96 H 134 N 2 O 60・ 2H 2 O = 2312.146 C; 49.87 H; 6.01 N; 1.21 Measured value C; 49.55 H; 5.79 N; 1.23 1 H-NMR (400 MHz, CDCl 3 ) δ; 2.192-
1.902 (ms, 69H, COCH 3 ), 1.203, 1.154, (2 × d, 2
× 3H, H-6e, g, J = 6.7Hz)

【0052】 〔参考例11〕(化合物〔1〕(2Lex )の合成) 化合物〔23〕1.2mg(3.8×10-4mM)をTHF0.
5mlに溶解し、これにテトラn−ブチルアンモニウムフ
ルオライドのTHF1M溶液5μlを加え、室温にて終
夜撹拌した。反応溶液を減圧下留去し、残渣をメタノー
ル/THF(0.5ml/0.5ml)に溶解し、これに、0.2
N NaOMe /メタノール溶液0.1mlを加え、室温にて4
時間撹拌した。反応終了後、アンバーリスト15を加え
反応溶液を中和後、不溶液をセライトよりろ去した。ろ
液を濃縮後、残渣をゲルろ過法(LH−20、クロロホ
ルム/メタノール/水=60/40/4.6)にて精製
し、化合物〔1〕0.5mg(収率、4.8%)を得た。 Rf=0.43 (n−ブタノール/エタノール/水=2
/1/1)1 H−NMR(400MHz、d6-DMSO )δ;5.544 (d
f, 1H, H-5Cer, J=6.1,14.6Hz), 5.357 (dd, 1H, H-4Ce
r, J=7.3, 15.1Hz), 4.853 (d, 2H, H-1d, g, J=3.4H
z), 4.730 (d, 1H, H-1c, J=7.6Hz), 4.714 (d, 1H, H-
1f ), 4.624 (q, 2H, H-5d, g, J=6.1Hz), 4.337 (d, 1
H, H-1e, J=6.8Hz), 4.291 (d, 1H, H-1h,J=6.8Hz), 4.
267 (d, 1H, H-1b ), 4.168 (d, 1H, H-1a, J=7.8Hz),
3.065 (t,1H, H-2a, J=7.8Hz), 2.026 (t, 1H, H-2 ′C
er, J=7.5Hz), 1.907 (s, 6H, 2×NAc ), 1.007 (d, 6
H, H-6d, g, J=6.3Hz), 0.853 (t, 6H, 2×CH3 Cer ,
J=6.3Hz)
Reference Example 11 (Synthesis of Compound [1] (2Le x )) Compound [23] 1.2 mg (3.8 × 10 −4 mM) was added with THF 0.2.
It was dissolved in 5 ml, 5 μl of a THF 1M solution of tetra-n-butylammonium fluoride was added thereto, and the mixture was stirred at room temperature overnight. The reaction solution was distilled off under reduced pressure, and the residue was dissolved in methanol / THF (0.5 ml / 0.5 ml), to which 0.2
Add 0.1 ml of N NaOMe / methanol solution, and add 4 at room temperature.
Stirred for hours. After the reaction was completed, Amberlyst 15 was added to neutralize the reaction solution, and the insoluble solution was filtered off from Celite. After concentrating the filtrate, the residue was purified by gel filtration (LH-20, chloroform / methanol / water = 60/40 / 4.6), and compound [1] 0.5 mg (yield, 4.8% ) Got. Rf = 0.43 (n-butanol / ethanol / water = 2
/ 1/1) 1 H-NMR (400 MHz, d 6 -DMSO) δ; 5.544 (d
f, 1H, H-5Cer, J = 6.1,14.6Hz), 5.357 (dd, 1H, H-4Ce
r, J = 7.3, 15.1Hz), 4.853 (d, 2H, H-1d, g, J = 3.4H
z), 4.730 (d, 1H, H-1c, J = 7.6Hz), 4.714 (d, 1H, H-
1f), 4.624 (q, 2H, H-5d, g, J = 6.1Hz), 4.337 (d, 1
H, H-1e, J = 6.8Hz), 4.291 (d, 1H, H-1h, J = 6.8Hz), 4.
267 (d, 1H, H-1b), 4.168 (d, 1H, H-1a, J = 7.8Hz),
3.065 (t, 1H, H-2a, J = 7.8Hz), 2.026 (t, 1H, H-2′C
er, J = 7.5Hz), 1.907 (s, 6H, 2 × NAc), 1.007 (d, 6
H, H-6d, g, J = 6.3Hz), 0.853 (t, 6H, 2 × CH 3 Cer,
(J = 6.3Hz)

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 一般式〔I〕で表わされるスフィンゴ糖
脂質関連化合物。 【化1】 式中、R1 、R2 及びR3 は独立して水素原子、ベンジ
ル基またはアセチル基であり、R4 はフタロイルアミノ
基またはアセチルアミノ基であり、R5 はベンジル基、
アセチル基又は-C(=NH)-CCl3基である。
1. A glycosphingolipid-related compound represented by the general formula [I]. Embedded image In the formula, R 1 , R 2 and R 3 are independently a hydrogen atom, a benzyl group or an acetyl group, R 4 is a phthaloylamino group or an acetylamino group, R 5 is a benzyl group,
An acetyl group or a -C (= NH) -CCl 3 group.
【請求項2】 R1 がベンジル基であり、R2 がアセチ
ル基であり、R3 が水素原子であり、R4 がフタロイル
アミノ基であり、R5 がベンジル基である請求項1記載
の化合物。
2. The method according to claim 1, wherein R 1 is a benzyl group, R 2 is an acetyl group, R 3 is a hydrogen atom, R 4 is a phthaloylamino group, and R 5 is a benzyl group. Compound of.
【請求項3】 R1 がベンジル基であり、R2 がアセチ
ル基であり、R3 がアセチル基であり、R4 がアセチル
アミノ基であり、R5 がベンジル基である請求項1記載
の化合物。
3. The method according to claim 1, wherein R 1 is a benzyl group, R 2 is an acetyl group, R 3 is an acetyl group, R 4 is an acetylamino group, and R 5 is a benzyl group. Compound.
【請求項4】 R1 、R2 及びR3 がアセチル基であ
り、R4 がアセチルアミノ基であり、R5 がアセチル基
である請求項1記載の化合物。
4. The compound according to claim 1 , wherein R 1 , R 2 and R 3 are acetyl groups, R 4 is an acetylamino group and R 5 is an acetyl group.
【請求項5】 R1 、R2 及びR3 がアセチル基であ
り、R4 がアセチルアミノ基であり、R5 が-C(=NH)-CC
l3基である請求項1記載の化合物。
5. R 1 , R 2 and R 3 are acetyl groups, R 4 is an acetylamino group, and R 5 is -C (= NH) -CC.
The compound according to claim 1, which is an l 3 group.
JP8643394A 1994-04-25 1994-04-25 Novel glycosphingolipid-related compounds Expired - Lifetime JPH0819161B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8643394A JPH0819161B2 (en) 1994-04-25 1994-04-25 Novel glycosphingolipid-related compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8643394A JPH0819161B2 (en) 1994-04-25 1994-04-25 Novel glycosphingolipid-related compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP30743186A Division JPH0689042B2 (en) 1986-12-23 1986-12-23 Method for producing glycosphingolipid-related compound

Publications (2)

Publication Number Publication Date
JPH07118302A JPH07118302A (en) 1995-05-09
JPH0819161B2 true JPH0819161B2 (en) 1996-02-28

Family

ID=13886783

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8643394A Expired - Lifetime JPH0819161B2 (en) 1994-04-25 1994-04-25 Novel glycosphingolipid-related compounds

Country Status (1)

Country Link
JP (1) JPH0819161B2 (en)

Also Published As

Publication number Publication date
JPH07118302A (en) 1995-05-09

Similar Documents

Publication Publication Date Title
ES2423888T3 (en) Synthetic heparin pentasaccharides
Murakata et al. Stereoselective total synthesis of the glycosyl phosphatidylinositol (GPI) anchor of Trypanosoma brucei
US4987223A (en) Derivatives of the uronic acid
WO1984001777A1 (en) Method for carrying out the organic synthesis of oligosaccharides containing galactosamine-uronic acid patterns, new oligosaccharides obtained and biological applications thereof
JPH0899989A (en) New glycolipid derivative and intermediate for its production
JPS6127000B2 (en)
JP2021505706A (en) Method for preparing octacarbonate of the outer core of helicobacter-pyrrolilipo polysaccharide
CA1328450C (en) Sulfated oligosaccharides and derivatives thereof
EP0204344A2 (en) Sialosylcerebrosides and a preparation method thereof
JPH0689042B2 (en) Method for producing glycosphingolipid-related compound
JPH0819161B2 (en) Novel glycosphingolipid-related compounds
US10669353B2 (en) Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharide
Sakairi et al. Synthesis of a 4′-amino-4′, 6′-dideoxymaltose derivative as a synthon of an α-d-glucosidase inhibitor
JPS61282390A (en) S-neuraminic acid derivative
JPH0558639B2 (en)
JP3025056B2 (en) Method for producing 2,6-dideoxy-2-fluoro-L-talopyranose derivative
JPH0676429B2 (en) Synthesis of lacto-series glycosphingolipids
RU2047619C1 (en) Method of synthesis of 2′, 3′-didehydro-3′-deoxythymidine
JPH024801A (en) Novel compound of relation to sphingoglycolipid and production thereof
JPH0952902A (en) Fluorine-containing sialyl-lewis x derivative and its synthetic intermediate
JPH0270701A (en) Manufacture of oligogalacturonic acid
Compain-Batissou et al. Anchimeric assistance by the anomeric phenylthio group in the nucleophilic substitution of a 6-O-trifluoromethanesulfonyl-β-d-galactopyranoside
JPH03279394A (en) Glycolipid and production thereof
JPS6335589A (en) X type neosphingolipid-relating compound and synthesis thereof
JPH0692985A (en) New maltose derivative and its production